Literature DB >> 16269224

A 5'-nuclease real-time reverse transcriptase-polymerase chain reaction assay for the detection of a broad range of influenza A subtypes, including H5N1.

David M Whiley1, Theo P Sloots.   

Abstract

A 5'-nuclease real-time reverse transcriptase-polymerase chain reaction assay was developed for the detection of influenza type A and was validated using a range of influenza A subtypes, including avian strains, and 126 nasopharyngeal aspirate samples. The results show the assay is suitable for screening for influenza A infections, particularly in regions where avian strains may be circulating.

Entities:  

Mesh：

Year:  2005        PMID： 16269224     DOI： 10.1016/j.diagmicrobio.2005.08.002

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  21 in total

1.  Influenza A viruses control expression of proviral human p53 isoforms p53β and Delta133p53α.

Authors:  Olivier Terrier; Virginie Marcel; Gaëlle Cartet; David P Lane; Bruno Lina; Manuel Rosa-Calatrava; Jean-Christophe Bourdon
Journal:  J Virol       Date:  2012-05-30       Impact factor: 5.103

2.  Rapid detection of respiratory tract viral infections and coinfections in patients with influenza-like illnesses by use of reverse transcription-PCR DNA microarray systems.

Authors:  Fanny Renois; Déborah Talmud; Antoine Huguenin; Lauryane Moutte; Christophe Strady; Joel Cousson; Nicolas Lévêque; Laurent Andréoletti
Journal:  J Clin Microbiol       Date:  2010-08-25       Impact factor: 5.948

Review 3.  Detection of respiratory viruses by molecular methods.

Authors:  James B Mahony
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

4.  Rapid semi-automated quantitative multiplex tandem PCR (MT-PCR) assays for the differential diagnosis of influenza-like illness.

Authors:  Elektra Szewczuk; Kiran Thapa; Terry Anninos; Kenneth McPhie; Geoff Higgins; Dominic E Dwyer; Keith K Stanley; Jonathan R Iredell
Journal:  BMC Infect Dis       Date:  2010-05-11       Impact factor: 3.090

5.  Pandemic influenza (H1N1) 2009 pneumonia: CURB-65 score for predicting severity and nasopharyngeal sampling for diagnosis are unreliable.

Authors:  Siobhain Mulrennan; Simone Sara Tempone; Ivan Thian Wai Ling; Simon Hedley Williams; Gek-Choo Gan; Ronan John Murray; David John Speers
Journal:  PLoS One       Date:  2010-09-21       Impact factor: 3.240

6.  Universal detection and identification of avian influenza virus by use of resequencing microarrays.

Authors:  Baochuan Lin; Anthony P Malanoski; Zheng Wang; Kate M Blaney; Nina C Long; Carolyn E Meador; David Metzgar; Christopher A Myers; Samuel L Yingst; Marshall R Monteville; Magdi D Saad; Joel M Schnur; Clark Tibbetts; David A Stenger
Journal:  J Clin Microbiol       Date:  2009-03-11       Impact factor: 5.948

7.  Direct sequence detection of structured h5 influenza viral RNA.

Authors:  Matthew B Kerby; Sarah Freeman; Kristina Prachanronarong; Andrew W Artenstein; Steven M Opal; Anubhav Tripathi
Journal:  J Mol Diagn       Date:  2008-04-10       Impact factor: 5.568

8.  Duplex real-time reverse transcriptase PCR assays for rapid detection and identification of pandemic (H1N1) 2009 and seasonal influenza A/H1, A/H3, and B viruses.

Authors:  Glenys Chidlow; Gerald Harnett; Simon Williams; Avram Levy; David Speers; David W Smith
Journal:  J Clin Microbiol       Date:  2010-01-13       Impact factor: 5.948

9.  Community-acquired pneumonia due to pandemic A(H1N1)2009 influenzavirus and methicillin resistant Staphylococcus aureus co-infection.

Authors:  Ronan J Murray; James O Robinson; Jodi N White; Frank Hughes; Geoffrey W Coombs; Julie C Pearson; Hui-Leen Tan; Glenys Chidlow; Simon Williams; Keryn J Christiansen; David W Smith
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

10.  Proficiency of nucleic acid tests for avian influenza viruses, Australasia.

Authors:  Sacha Stelzer-Braid; Ros Escott; Cristina Baleriola; Peter Kirkland; Peter Robertson; Michael Catton; William D Rawlinson
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.